JP Morgan Private Wealth Advisors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,047
| Closed | -$347K | – | 1668 |
|
|
2023
Q1 | $347K | Buy |
6,047
+120
| +2% | +$6.76K | ﹤0.01% | 1616 |
|
|
2022
Q4 | $332K | Buy |
+5,927
| New | +$302K | ﹤0.01% | 1621 |
|
|
2022
Q3 | – | Sell |
-5,616
| Closed | -$303K | – | 1948 |
|
|
2022
Q2 | $303K | Sell |
5,616
-283
| -5% | -$17K | ﹤0.01% | 1644 |
|
|
2022
Q1 | $379K | Buy |
5,899
+479
| +9% | +$31.5K | ﹤0.01% | 1651 |
|
|
2021
Q4 | $363K | Sell |
5,420
-451
| -8% | -$30.5K | ﹤0.01% | 1668 |
|
|
2021
Q3 | $402K | Buy |
5,871
+419
| +8% | +$29.6K | ﹤0.01% | 1589 |
|
|
2021
Q2 | $372K | Buy |
5,452
+531
| +11% | +$37.5K | ﹤0.01% | 1600 |
|
|
2021
Q1 | $340K | Buy |
4,921
+84
| +2% | +$5.69K | ﹤0.01% | 1472 |
|
|
2020
Q4 | $314K | Buy |
4,837
+317
| +7% | +$17.1K | ﹤0.01% | 1480 |
|
|
2020
Q3 | $213K | Buy |
4,520
+235
| +5% | +$11.2K | ﹤0.01% | 1502 |
|
|
2020
Q2 | $201K | Sell |
4,285
-1,317
| -24% | -$64.7K | ﹤0.01% | 1462 |
|
|
2020
Q1 | $250K | Buy |
5,602
+1,993
| +55% | +$105K | ﹤0.01% | 1198 |
|
|
2019
Q4 | $210K | Sell |
3,609
-837
| -19% | -$49.8K | ﹤0.01% | 1384 |
|
|
2019
Q3 | $267K | Buy |
4,446
+367
| +9% | +$21.9K | ﹤0.01% | 1231 |
|
|
2019
Q2 | $228K | Sell |
4,079
-502
| -11% | -$25.9K | ﹤0.01% | 1255 |
|
|
2019
Q1 | $255K | Buy |
+4,581
| New | +$233K | ﹤0.01% | 1282 |
|
|
2018
Q4 | – | Sell |
-4,266
| Closed | -$281K | – | 1522 |
|
|
2018
Q3 | $281K | Sell |
4,266
-523
| -11% | -$32.5K | ﹤0.01% | 1329 |
|
|
2018
Q2 | $308K | Buy |
4,789
+55
| +1% | +$3.41K | ﹤0.01% | 1197 |
|
|
2018
Q1 | $262K | Sell |
4,734
-578
| -11% | -$30.3K | ﹤0.01% | 1092 |
|
|
2017
Q4 | $254K | Buy |
5,312
+704
| +15% | +$34.5K | ﹤0.01% | 1106 |
|
|
2017
Q3 | $233K | Sell |
4,608
-466
| -9% | -$23.9K | ﹤0.01% | 1105 |
|
|
2017
Q2 | $277K | Buy |
5,074
+295
| +6% | +$14.1K | ﹤0.01% | 1043 |
|
|
2017
Q1 | $201K | Sell |
4,779
-217
| -4% | -$9.27K | ﹤0.01% | 1245 |
|
|
2016
Q4 | $214K | Sell |
4,996
-3,490
| -41% | -$142K | ﹤0.01% | 1137 |
|
|
2016
Q3 | $350K | Sell |
8,486
-3,854
| -31% | -$161K | ﹤0.01% | 921 |
|
|
2016
Q2 | $492K | Sell |
12,340
-4,640
| -27% | -$167K | ﹤0.01% | 785 |
|
|
2016
Q1 | $572K | Buy |
16,980
+5,100
| +43% | +$159K | 0.01% | 703 |
|
|
2015
Q4 | $403K | Hold |
11,880
| – | – | ﹤0.01% | 758 |
|
|
2015
Q3 | $354K | Sell |
11,880
-14,358
| -55% | -$449K | ﹤0.01% | 733 |
|
|
2015
Q2 | $722K | Sell |
26,238
-2,283
| -8% | -$60.8K | 0.01% | 580 |
|
|
2015
Q1 | $719K | Buy |
28,521
+631
| +2% | +$14.9K | 0.01% | 612 |
|
|
2014
Q4 | $618K | Buy |
27,890
+9,639
| +53% | +$195K | 0.01% | 644 |
|
|
2014
Q3 | $370K | Hold |
18,251
| – | – | ﹤0.01% | 782 |
|
|
2014
Q2 | $351K | Sell |
18,251
-2,520
| -12% | -$47K | 0.01% | 673 |
|
|
2014
Q1 | $390K | Buy |
+20,771
| New | +$401K | 0.01% | 646 |
|
Other funds holding IART
CIP
CB
JP Morgan Private Wealth Advisors's IART Position: Q2 2023 in Review
JP Morgan Private Wealth Advisors sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 6,047 shares — an estimated $347K sold.
JP Morgan Private Wealth Advisors first reported a position in IART in Q1 2014 and held it in 35 quarters. The position peaked at $722K in Q2 2015. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.
- JP Morgan Private Wealth Advisors reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
- JP Morgan Private Wealth Advisors sold 6,047 Integra LifeSciences shares in Q2 2023, an estimated $347K.
- JP Morgan Private Wealth Advisors first reported a position in Integra LifeSciences in Q1 2014 and held it in 35 quarters.
- JP Morgan Private Wealth Advisors's Integra LifeSciences position peaked at $722K in Q2 2015.
- 283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.